UBS Group’s Enveric Biosciences ENVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.1K | Sell |
27,339
-15,421
| -36% | -$18.7K | ﹤0.01% | 6790 |
|
|
2025
Q1 | $59.4K | Buy |
42,760
+37,533
| +718% | +$52.2K | ﹤0.01% | 6162 |
|
|
2024
Q4 | $28.1K | Buy |
5,227
+5,178
| +10,567% | +$27.8K | ﹤0.01% | 6431 |
|
|
2024
Q3 | $346 | Sell |
49
-2,855
| -98% | -$20.2K | ﹤0.01% | 7771 |
|
|
2024
Q2 | $27.3K | Buy |
2,904
+2,572
| +775% | +$24.2K | ﹤0.01% | 5964 |
|
|
2024
Q1 | $4.98K | Buy |
332
+331
| +33,100% | +$4.97K | ﹤0.01% | 6398 |
|
|
2023
Q4 | $13 | Sell |
1
-20
| -95% | -$260 | ﹤0.01% | 7887 |
|
|
2023
Q3 | $740 | Buy |
21
+17
| +425% | +$599 | ﹤0.01% | 7159 |
|
|
2023
Q2 | $182 | Sell |
4
-351
| -99% | -$16K | ﹤0.01% | 7335 |
|
|
2023
Q1 | $8.85K | Buy |
355
+195
| +122% | +$4.86K | ﹤0.01% | 6594 |
|
|
2022
Q4 | $5.01K | Sell |
160
-187
| -54% | -$5.85K | ﹤0.01% | 8037 |
|
|
2022
Q3 | $22K | Buy |
347
+346
| +34,600% | +$21.9K | ﹤0.01% | 6162 |
|
|
2022
Q2 | $0 | Sell |
1
-130
| -99% | – | ﹤0.01% | 9358 |
|
|
2022
Q1 | $32K | Buy |
131
+112
| +589% | +$27.4K | ﹤0.01% | 5887 |
|
|
2021
Q4 | $13K | Buy |
19
+18
| +1,800% | +$12.3K | ﹤0.01% | 7320 |
|
|
2021
Q3 | $1K | Sell |
1
-89
| -99% | -$89K | ﹤0.01% | 8017 |
|
|
2021
Q2 | $160K | Buy |
90
+48
| +114% | +$85.3K | ﹤0.01% | 4496 |
|
|
2021
Q1 | $97K | Buy |
+42
| New | +$97K | ﹤0.01% | 5003 |
|
|
2020
Q3 | – | Hold |
0
| – | -$2K | – | 7150 |
|
|
2020
Q2 | – | Sell |
-2
| Closed | -$5K | – | 6763 |
|
|
2020
Q1 | $5K | Buy |
+2
| New | +$5K | ﹤0.01% | 6362 |
|
|
2019
Q4 | – | Sell |
-1
| Closed | -$9K | – | 7046 |
|
|
2019
Q3 | $9K | Buy |
+1
| New | +$9K | ﹤0.01% | 6242 |
|
|
2019
Q2 | – | Sell |
-1
| Closed | -$18K | – | 7007 |
|
|
2019
Q1 | $18K | Buy |
+1
| New | +$18K | ﹤0.01% | 5551 |
|
|
2018
Q4 | – | Hold |
0
| – | -$25K | – | 6692 |
|
|
2018
Q3 | – | Hold |
0
| – | -$9K | – | 5750 |
|
|
2018
Q2 | – | Hold |
0
| – | -$1K | – | 6263 |
|
|
2018
Q1 | – | Hold |
0
| – | -$1K | – | 6732 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6721 |
|